Karin L. Walker - Jun 15, 2021 Form 4 Insider Report for Cyclacel Pharmaceuticals, Inc. (CYCC)

Role
Director
Signature
/s/ Karin Walker
Stock symbol
CYCC
Transactions as of
Jun 15, 2021
Transactions value $
$0
Form type
4
Date filed
6/17/2021, 04:07 PM
Next filing
Oct 22, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYCC Common Stock Award $0 +2.37K +200% $0.00 3.56K Jun 15, 2021 Direct F1
transaction CYCC Common Stock Award $0 +1.19K +50% $0.00 3.56K Jun 15, 2021 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYCC Stock Option (right to buy) Award $0 +4.75K +200% $0.00 7.12K Jun 15, 2021 Common Stock 4.75K $6.69 Direct F3
transaction CYCC Stock Option (right to buy) Award $0 +2.37K +50% $0.00 7.12K Jun 15, 2021 Common Stock 2.37K $6.69 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person received an award of 2,374 restricted stock units on June 15, 2021, which shall vest in full on June 15, 2022.
F2 The reporting person received an award of 1,187 restricted stock units on June 15, 2021, which shall vest in three equal installments on June 15, 2022, June 15, 2023, and June 15, 2024.
F3 These options were granted to Ms. Walker for her services as a member of the board of directors of Cyclacel Pharmaceuticals, Inc.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney